 |
|
|
| |
ABX464 Decreases Total HIV DNA and Integrated HIV DNA in PBMCs When Administered During 28 Days to HIV-infected Virologically Suppressed Patients
|
| |
| |
Reported by Jules Levin
16th European Aids Conference
Milano
October 26, 2017
Linos Vandekerckhove 1 , Roger Paredes 2, Bonaventura Clotet 2, Michel Moutschen 3, Stéphane De Wit 4, Daniel Podzamczer 5, Laurent Cotte 6, Jacques Reynes 7, Sofie Rutsaert 1, Basiel Cole 1 , Sam Kint 1 , Paul Gineste 8, Hartmut Ehrlich 8, Jean-Marc Steens 8*
1HIV Cure Research Center, Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium; 2Infectious Diseases & IrsiCaixa, Hospital
Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; 3Médecine Interne/infectiologie CHU Sart Tilman, Liege, Belgium; 4C.H.U. Saint-Pierre, Brussels, Belgium; 5Hospital Universitari de Bellvitge, Barcelona, Spain; 6Hopital de la Croix-Rousse, Lyon, France; 7Hopital Gui de Chauliac, Montpellier, France; 8ABIVAX, Paris, France. *Corresponding author: jean-marc.steens@abivax.com
|
| |
|
|
|
|
|
